Literature DB >> 11090234

The Canadian SCORE questionnaire: optimizing the use of technology for low bone density assessment. Simple Calculated Osteoporosis Risk Estimate.

W J Ungar1, R Josse, S Lee, N Ryan, R Adachi, D Hanley, J Brown, M C Breton.   

Abstract

The Simple Calculated Osteoporosis Risk Estimation (SCORE) questionnaire is a tool to assist physicians to identify women who might require bone densitometry. The purpose of this study was to develop a Canadian SCORE and to assess validity and reliability. Twenty sites enrolled 307 postmenopausal women ages 50-70 yr. SCORE results were compared to hip and lumbar spine bone density assessed by dual X-ray absorptiometry. Sensitivity and specificity of a range of SCORE cut-points were assessed in a receiver operating characteristics analysis to determine the optimal cut-point for SCORE. With low bone density defined as a T-score < or = -2.0, a SCORE cut-point of 6 in women ages 50-59 yr displayed a sensitivity of 0. 96, 95% confidence interval (CI) (0.89, 1.00), a specificity of 0.51, 95% CI (0.43, 0.58). In women ages 60-70 yr, a SCORE cut-point of 8 displayed a sensitivity of 0.90, 95% CI (0.80, 0.97) and a specificity of 0.20, 95% CI (0.11, 0.29). The test-retest reliability (intraclass correlation coefficient) was 0.95. SCORE performed better in women in their fifties than women in ther sixties. Older women require higher SCORE cut-points. The use of SCORE as an initial measure for identifying those at risk for osteoporosis may reduce costs by limiting unnecessary tests.

Entities:  

Mesh:

Year:  2000        PMID: 11090234     DOI: 10.1385/jcd:3:3:269

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  10 in total

1.  Osteoporosis case finding in the general practice: phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometry.

Authors:  Katharina M Gasser; Christian Mueller; Marcel Zwahlen; Manfred Kaufmann; Gaby Fuchs; Romain Perrelet; Gilbert Abetel; Ulrich Bürgi; Kurt Lippuner
Journal:  Osteoporos Int       Date:  2005-02-12       Impact factor: 4.507

2.  Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry.

Authors:  B Rud; J E B Jensen; L Mosekilde; S P Nielsen; J Hilden; B Abrahamsen
Journal:  Osteoporos Int       Date:  2004-09-30       Impact factor: 4.507

3.  Canadian Consensus Conference on osteoporosis, 2006 update.

Authors:  Jacques P Brown; Michel Fortier; Heather Frame; André Lalonde; Alexandra Papaioannou; Vyta Senikas; Chui Kin Yuen
Journal:  J Obstet Gynaecol Can       Date:  2006-02

4.  Diagnostic thresholds in osteoporosis: how are they used in clinical trials?

Authors:  Ronald C Hamdy; Dustin M Price; Miriam M Mottl
Journal:  Curr Osteoporos Rep       Date:  2011-09       Impact factor: 5.096

5.  Comparison of questionnaire and quantitative ultrasound techniques as screening tools for DXA.

Authors:  R B Cook; D Collins; J Tucker; P Zioupos
Journal:  Osteoporos Int       Date:  2005-05-10       Impact factor: 4.507

6.  Which screening strategy using BMD measurements would be most cost effective for hip fracture prevention in elderly women? A decision analysis based on a Markov model.

Authors:  A M Schott; C Ganne; D Hans; G Monnier; R Gauchoux; M A Krieg; P D Delmas; P J Meunier; C Colin
Journal:  Osteoporos Int       Date:  2006-10-13       Impact factor: 4.507

Review 7.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

Review 8.  Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review.

Authors:  Carolyn J Crandall
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

9.  Performance of simple calculated osteoporosis risk estimation in a sample of women with suspected osteoporosis in the Turkish population.

Authors:  M Karkucak; E Capkin; S Kerimoglu; M Serdaroglu; M Topbas; H Yildiz; M Guler
Journal:  Rheumatol Int       Date:  2008-02-27       Impact factor: 2.631

10.  Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density.

Authors:  Fausto Salaffi; Ferdinando Silveri; Andrea Stancati; Walter Grassi
Journal:  Clin Rheumatol       Date:  2004-11-12       Impact factor: 2.980

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.